The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Larina A.A.

FGBU "Éndokrinologicheskiĭ nauchnyĭ tsentr" MZ RF, Moskva

Grigorian O.R.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia Rossii, Moskva

Andreeva E.N.

Mediko-geneticheskoe otdelenie Moskovskogo oblastnogo NII akusherstva i ginekologii

Dzeranova L.K.

ndokrinologicheskiĭ nauchnyĭ tsentr Minzdrava RF, Moskva

The hyperprolactinemia and pregnancy (a review)

Authors:

Larina A.A., Grigorian O.R., Andreeva E.N., Dzeranova L.K.

More about the authors

Journal: Russian Journal of Human Reproduction. 2013;(3): 13‑17

Read: 22654 times

Download PDF (RU)
Contact the author
Table of contents

THE HYPERPROLACTINEMIA AND PREGNANCY (A REVIEW)
THE HYPERPROLACTINEMIA AND PREGNANCY (A REVIEW)

To cite this article:

Larina AA, Grigorian OR, Andreeva EN, Dzeranova LK. The hyperprolactinemia and pregnancy (a review). Russian Journal of Human Reproduction. 2013;(3):13‑17. (In Russ.)

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Local cyto­kine profile of the endo­metrium in patients with repeated implantation failures and its pharmacological correction by the secretome of peri­pheral blood mono­nuclear cells. Russian Journal of Human Reproduction. 2024;(5):46-54
Immu­nological aspe­cts of reccurent pregnancy loss. Russian Journal of Human Reproduction. 2024;(5):64-71
Functional cyto­kine redu­ndancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80
Clinical case of successful pregnancy in a patient with ecto­pic ACTH syndrome after radi­cal surgical treatment. Russian Journal of Human Reproduction. 2024;(6):118-123
Pecu­liarities of placental microRNA expression in patients with preeclampsia and fetal growth restriction. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):14-25
Changes in the type of psychological component of the gestational domi­nant in pregnant women in the third trimester after completing the peri­natal preparation program. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):66-71
Sexual function of women during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):112-117
Dyna­mics of Substance P and Fila­ggrin Levels on Combined Treatment of Atopic Dermatitis with Emollient and Topi­cal Anti­pruritic Drug in Pregnant Women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):662-666
Diabetic reti­nopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Abstract:

The pregnancy is accompanied by serious hormonal transformations. Usually microprolactinomas and macroprolactinomas do not grow during pregnancy, but the risk of prolactinoma growth without surgery and radiotherapy can increase up to 31%. The appearance or aggravation of headache in addition to eye-sight losing is a serious reason for visual sectors studying and magnetic resonance tomography (without contrast).

Keywords:

hyperprolactinemia
pregnanc

Authors:

Larina A.A.

FGBU "Éndokrinologicheskiĭ nauchnyĭ tsentr" MZ RF, Moskva

Grigorian O.R.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia Rossii, Moskva

Andreeva E.N.

Mediko-geneticheskoe otdelenie Moskovskogo oblastnogo NII akusherstva i ginekologii

Dzeranova L.K.

ndokrinologicheskiĭ nauchnyĭ tsentr Minzdrava RF, Moskva

Close metadata

References:

  1. Dedov I.I., Mel'nichenko G.A., Romantsova T.I. Sindrom giperprolaktinemii. M-Tver': Triada 2004; 304.
  2. Dzeranova L.K., Bykanova N.S., Pigarova E.A. Giperprolaktinemiya i beremennost': osnovnye dostizheniya i nereshennye voprosy. Vestn reprod zdorov'ya 2011; 1: 16-22.
  3. Zhukova E.V., Mel'nichenko G.A., Romantsova T.I., Dzeranova L.K. Beremennost' i rody u bol'nykh s giperprolaktinemicheskim gipogonadizmom. Vestn reprod zdorov'ya 2009; 1: 2-7.
  4. Barlier A., Jaquet P. Quinagolide - a valuable treatment option for hyperprolactinaemia. Eur J Endocrinol 2006; 154: 187-195.
  5. Chiodini I., Liuzzi A. PRL-secreting pituitary adenomas in pregnancy. J Endocrinol Inv 2003; 26: 96-99.
  6. Czeizel A., Kiss R., Racz K., Mohori K., Glaz E. Case-control cytogenetic study in offspring of mothers treated with bromocriptine during early pregnancy. Mutat Res 1989; 210: 23-27.
  7. Gillam M.P., Molitch M.E., Lombardi G., Colao A. Advances in the treatment of prolactinomas. Endocrinol Rev 2006; 27: 485-534.
  8. Heaney A.P., Fernando M., Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J Clin Inv 2002; 109: 277-283.
  9. Johnston D.G., Prescott R.W., Kendall-Taylor P., Hall K., Crombie A.L., Hall R., McGregor A., Watson M.J., Cook D.B. Hyperprolactinemia. Long-term effects of bromocriptine. Am J Med 1983; 75: 868-874.
  10. Karaca Z., Tanriverdi F., Unluhizarci K., Kelestimur F. Pregnancy and pituitary disordes. Eur J Endocrinol 2010; 162: 3: 453-475.
  11. Krupp P., Monka C. Bromocriptine in pregnancy: safety aspects. Klin Wochenschrift 1987; 65: 823-827.
  12. Melmed S., Casanueva F., Hoffman A., Kleinberg D., Montori V., Schlechte J., Wass J. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol 2011; 96: 2: 273-288.
  13. Molitch M.E. Pituitary disorders during pregnancy. Endocrinol Metabol Clin North Am 2006; 35: 99-116.
  14. Molitch M.E. Prolactinomas and pregnancy. Clin Endocrinol 2010; 73: 147-148.
  15. Motazedian S., Babakhani L., Fereshtehnejad S.-M., Mojtahedi K. A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination. Indian J Med Res 2010; 131: 670-674.
  16. Ono M., Miki N., Amano K., Kawamata T., Seki T., Makino R., Takano K., Izumi S., Okada Y., Hori T. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metabol 2010; 95: 6: 2672-2679.
  17. Raymond J.P., Goldstein E., Konopka P., Leleu M.F., Merceron R.E., Loria Y. Follow-up of children born of bromocriptine-treated mothers. Horm Res 1985; 22: 239-246.
  18. Sarno A.D., Landi M.L., Cappabianca P., Salle F.D., Colao A. et al. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. J Clin Endocrinol Metabol 2001; 86: 11: 5256-5261.
  19. Stalldecker G., Mallea-Gil M.S., Guitelman M. et al. Effects of cabergolin on pregnancy and embryo-fetal development: retrospective study of 103 pregnancies and a review of literature. Pituitary 2010; 13: 4: 345-350.
  20. Thorner M.O., Bronstein M. Pituitary disease and neuroendocrinology. Ed. A. Grossman. Prolactin. Disorders 2011; 6.
  21. Webster J., Piscitelli G., Polli A., Ferrari C.I., Ismail I., Scanlon M.F. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med 1994; 6: 331: 14: 904-909.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.